The Pangaea Group
A Trusted Guide in Canada’s Pharmaceutical Terrain

In the ever-evolving landscape of Canadian pharmaceuticals, innovation knows no bounds. This dynamic terrain involves complex regulatory demands, where each province has distinct ownership of healthcare delivery, overall reimbursement (including drugs) and compliance laws. Faced with these complexities, domestic and foreign pharma companies looking to establish themselves in Canada seek a steady hand to navigate the challenges and harness their vast potential.

Amid this backdrop, The Pangaea Group, a boutique consulting firm, emerges as a formidable force, offering the much-needed expertise and insight that pharmaceutical companies require to gain a solid foothold in Canada. It assists in the initial risk/benefit analysis for companies that come to Canada due to a very small footprint as well as a robust private payer market.

The core team at Pangaea comprises directors with diverse backgrounds, including industry executives, pharmacists, medical doctors, and engineers. Drawing upon decades of experience, they bring a profound understanding of the local business landscape, equipping businesses for success in the Canadian market, regardless of the global locations or the type of pharmaceutical therapeutic focus.

“We help pharma organizations establish themselves in Canada by providing a comprehensive program that outlines the necessary steps, timelines, and resource requirements,” says Joe Knott, managing director of The Pangaea Group.

Through its program, Pangaea can efficiently establish a functioning virtual pharmaceutical company if there is a corporate appointed, such as general manager and a medical director. This helps postpone hiring additional staff until they fully comprehend Health Canada’s final approval and monograph, and payer reimbursement policies, effectively mitigating risk when commencing operations.

Pangaea’s consulting services in the Canadian pharma industry encompass trade, business, and corporate strategy development. Specializing in trade relations, it takes charge of the entire distribution channel for approximately 20 pharma companies in Canada. Its involvement begins with acquiring establishment licenses and extends into formulating strategic trade and product distribution approaches across an array of appropriate channels.

Pangaea offers a wide pallet of marketing and strategy expertise.

This includes strategic planning, brand planning facilitation, competitive assessment and simulation, advisory boards pricing and reimbursement advice, and life cycle management.

The firm adopts a supplier-neutral approach, placing the power in the hands of clients to establish their key performance metrics. It provides tailored dashboards for in-depth business analysis, supporting well-informed decision-making based on a comprehensive understanding of the client’s current circumstances and future prospects.

It executes various functions on behalf of its clients, managing cross-border operations and handling trade and group purchasing organization matters, enabling clients to focus squarely on their core priorities while relying on Pangaea’s expertise to efficiently handle these essential functions.

In recent years, Pangaea has expanded into data analytics, excelling in understanding key performance indicators, developing dashboards, and conducting annual benchmarking exercises involving over 20 companies. The insights gleaned from these exercises serve as valuable resources for pharma companies, offering them knowledge of best practices and standards across various domains.

Pangaea’s capabilities extend to nurturing talent within the pharma marketing field. It has introduced a four-day marketing program designed specifically for pharma marketers in Canada rooted in brand marketing principles. Leveraging its extensive industry network, the firm ropes in industry leaders to enhance the domain expertise of young marketers.

At the program’s onset, the experts equip attendees with a comprehensive understanding of Canada’s healthcare landscape. Attendees delve into SWOT analysis, service provider selection, product positioning, brand planning, cross-functional teamwork, and competitive analysis. The program’s primary focus is on interactivity, with workshops and case studies making up the majority of the content.

This hands-on approach equips marketers with immediately applicable skills. Pangaea also ensures that clients remain well-informed about industry trends and future directions, empowering them to develop effective strategic plans and stay ahead of emerging challenges through its publications.

To keep pharma businesses further informed, it publishes ‘Topics & Trends’, ‘Inside Trade’, and ‘Pangaea Express,’ an informative publication offering insights into industry related topics and trends.

With over 35 subscribing companies, it significantly enhances awareness of the challenges and opportunities presented by the Canadian business landscape and more importantly, the future outlook.

Built upon a foundation of researching and fulfilling customer needs, The Pangaea Group is driven by a deep commitment to ensure client success. With its consulting capabilities, industry expertise, and wide network, it has become a trusted partner for companies aspiring to excel in the Canadian pharma sector.